Dizal (Jiangsu) Pharmaceutical Co., Ltd.

SHSE:688192 Stock Report

Market Cap: CN¥17.5b

Dizal (Jiangsu) Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 688192?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders13,307,2723.2%
General Public48,602,82211.7%
Private Companies62,619,07115.1%
Institutions73,277,90917.6%
Public Companies108,923,02326.2%
VC/PE Firms108,923,02326.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 87.58% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.2%
AstraZeneca PLC
108,923,023CN¥4.6b0%no data
26.2%
SDIC Innovation Investment Management Co., Ltd.
108,923,023CN¥4.6b0%41.8%
13.8%
Jiangsu Wuxi Dizhe Enterprise Management Partnership Enterprise (Limited Partnership)
57,451,788CN¥2.4b0%no data
4.91%
Sequoia Capital Operations LLC
20,427,801CN¥860.4m0%0.61%
2.32%
Wuxi Xintou Jinshi Venture Capital Management Co., Ltd.
9,647,296CN¥406.3m0%no data
2.14%
Morgan Stanley, Investment Banking and Brokerage Investments
8,878,433CN¥374.0m0%0.01%
2.07%
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
8,595,927CN¥362.1m0%8.35%
1.76%
Zhang Xiaolin
7,310,972CN¥307.9m0%no data
1.24%
Dezent Partners Limited
5,167,283CN¥217.6m0%no data
1.09%
Zhenfan Yang
4,538,000CN¥191.1m49.3%no data
1.05%
Penghua Fund Management Co., Ltd.
4,365,195CN¥183.9m0%0.16%
1.05%
Shanghai Liyi Investment Management Partnership (Limited Partnership)
4,352,146CN¥183.3m0%14.05%
0.61%
Goldman Sachs Group, Investment Banking and Securities Investments
2,518,142CN¥106.1m0%0.01%
0.52%
Shanghai Sixie Investment Management Co., Ltd.
2,160,000CN¥91.0m0%5.73%
0.49%
China Fund Management Co., Ltd.
2,050,000CN¥86.3m0%1.01%
0.39%
Harvest Fund Management Co. Ltd.
1,604,097CN¥67.6m0%0.03%
0.37%
Trinity Innovation Fund
1,558,244CN¥65.6m0%no data
0.25%
The Vanguard Group, Inc.
1,049,184CN¥44.2m0%no data
0.24%
HuaAn Fund Management Company Ltd.
980,621CN¥41.3m0%0.03%
0.23%
GF Fund Management Co., Ltd.
975,110CN¥41.1m0%0.01%
0.14%
Hwabao WP Fund Management Co., Ltd
595,687CN¥25.1m0%0.03%
0.14%
Bosera Asset Management Co., Ltd.
578,564CN¥24.4m0%0.02%
0.11%
Ping An UOB Fund Management Co., Ltd.
476,693CN¥20.1m0%0.07%
0.11%
Suqin Chen
459,500CN¥19.4m49.3%no data
0.11%
China Asset Management Co. Ltd.
439,420CN¥18.5m0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.